Efficacy and safety of co-administered once-weekly cagrilintide 24 mg with once-weekly semaglutide 24 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
Cardiovascular Applications TB-500 has demonstrated significant cardiovascular benefits in preclinical investigations, particularly in models of myocardial injury and cardiac remodeling
Peptides may be effective for some
pre- and post-operative treatment, when requirements are increased as in fever, severe burns, increased metabolism, pregnancy, gastrointestinal disorders interfering with intake or absorption of vitamins, prolonged or wasting diseases, alcoholism and where other deficiencies exist
They are not approved for human or animal consumption, medical use, or diagnostic purposes
Our peptide stacking guide provides foundational principles, while the peptide stack calculator helps with dosing logistics